Presentation TCT 2016 Do the Benefits of Bivalirudin Translate to Radial Intervention? Evidence From Randomized Trials Presenter: A. Michael Lincoff, Franz-Josef Neumann, John A. Bittl October 30, 2016
Presentation TCT 2016 Should Bivalirudin Only Be Used With a Prolonged Post-PCI Infusion? Presenter: A. Michael Lincoff, Franz-Josef Neumann, Gregg W. Stone October 30, 2016
Presentation TCT 2016 Start With a Three-way Debate: Bivalirudin Is the Optimal Procedural Anticoagulant in STEMI Patients Undergoing Primary PCI! Presenter: A. Michael Lincoff, Franz-Josef Neumann, Harvey D. White October 30, 2016
Presentation TCT 2016 Start With a Three-way Debate: Heparin Plus Routine Use of GP IIb/IIIa Inhibitors Is the Optimal Procedural Anticoagulant in STEMI Patients Undergoing Primary PCI! Presenter: A. Michael Lincoff, Franz-Josef Neumann, Jorge F. Saucedo October 30, 2016
Presentation TCT 2016 Start With a Three-way Debate: Heparin Monotherapy Is the Optimal Procedural Anticoagulant in STEMI Patients Undergoing Primary PCI! Presenter: A. Michael Lincoff, Franz-Josef Neumann October 30, 2016
Presentation Prolonged High-Dose Bivalirudin Infusion Reduces Major Bleeding Without Increasing Stent Thrombosis in Patients Undergoing Primary PCI Presenter: Gregor Fahrni July 27, 2016
Presentation Effect of Post-PPCI Bivalirudin Infusion on Acute Stent Thrombosis: Meta-analysis of RCTs Presenter: Rahman Shah June 20, 2016
Presentation TCT 2015 Bivalirudin Versus Unfractionated Heparin Analysis: What Is Really Best in Which Patients? Presenter: Carlo Briguori, Roxana Mehran, Carey D. Kimmelstiel October 15, 2015
Presentation TCT 2015 BRAVO 3: A Prospective Randomized Trial of Bivalirudin Versus Heparin in Patients Undergoing Transcatheter Aortic Valve Replacement Presenter: Thierry Lefevre October 15, 2015
Presentation TCT 2015 Debate: Bivalirudin vs Heparin During PCI in Stable CAD? Unfractionated Heparin! Presenter: John A. Bittl, Robert A. Harrington, Michael S. Lee October 12, 2015
Presentation TCT 2015 Debate: Bivalirudin vs Heparin During PCI in Stable CAD? Bivalirudin! Presenter: John A. Bittl, Robert A. Harrington, George D. Dangas October 12, 2015
Presentation TCT 2015 Cangrelor + Bivalirudin: The Perfect Marriage or a Forced Union? Presenter: John A. Bittl, Robert A. Harrington, Harvey D. White October 12, 2015
Presentation TCT 2015 Bivalirudin Pearls: Necessity With Radial Access, Infusion Dose and Duration, Use in CKD, and More Presenter: John A. Bittl, Robert A. Harrington, Philippe Gabriel Steg October 12, 2015
Presentation TCT 2015 Bivalirudin vs Heparin in ACS: The New Data MATRIX Antithrombin Results Presenter: John A. Bittl, Robert A. Harrington, Marco Valgimigli October 12, 2015
Presentation TCT 2015 I Dont Believe Bivalirudin Should Routinely Be Used as the First-line Anticoagulant in Primary PCI! Presenter: Nick Curzen, Ajay J. Kirtane, David J. Cohen October 12, 2015
Presentation TCT 2015 Pharmacology in the Lab: Heparin or Bivalirudin? Presenter: Robert J. Applegate, Ehtisham Mahmud October 11, 2015
Presentation The Comparative Efficacy of Bivalirudin Is Markedly Attenuated by Use of Radial Access Presenter: E. Perdoncin October 02, 2015
Presentation Bivalirudin Is Associated With Improved Clinical and Economic Outcomes in HF Patients Undergoing PCI Presenter: DS. Pinto June 08, 2015
Presentation BRIGHT: Bivalirudin vs Heparin With or Without Tirofiban During Primary PCI in Acute MI Presenter: Yaling Han March 23, 2015
Presentation ACC 2015 Effect of REG1 Anticoagulation System vs_ Bivalirudin on Cardiovascular Outcomes Following PCI: The REGULATE-PCI Randomized Clinical Trial Presenter: Roxana Mehran March 15, 2015